 |
Previous Article | Next Article 
The Journal of Neuroscience, August 1, 2002, 22(15):6713-6723
Severe Impairment of NMDA Receptor Function in Mice Carrying
Targeted Point Mutations in the Glycine Binding Site Results in
Drug-Resistant Nonhabituating Hyperactivity
Theresa M.
Ballard1, *,
Meike
Pauly-Evers2, *,
Guy A.
Higgins1,
Abdel-Mouttalib
Ouagazzal1,
Vincent
Mutel1,
Edilio
Borroni1,
John A.
Kemp1,
Horst
Bluethmann2, and
James N. C.
Kew1
1 Preclinical CNS Research and 2 Roche
Genetics, F. Hoffmann-La Roche Limited, CH-4070 Basel, Switzerland
NMDA receptor hypofunction has been implicated in the
pathophysiology of schizophrenia, and pharmacological and genetic
approaches have been used to model such dysfunction. We
previously have described two mouse lines carrying point
mutations in the NMDA receptor glycine binding site,
Grin1D481N and
Grin1K483Q, which exhibit 5- and
86-fold reductions in receptor glycine affinity, respectively.
Grin1D481N animals exhibit a
relatively mild phenotype compatible with a moderate reduction in NMDA
receptor function, whereas Grin1K483Q
animals die shortly after birth. In this study we have characterized compound heterozygote Grin1D481N/K483Q
mice, which are viable and exhibited biphasic NMDA receptor glycine affinities compatible with the presence of each of the two mutated alleles. Grin1D481N/K483Q mice
exhibited a marked NMDA receptor hypofunction revealed by deficits in
hippocampal long-term potentiation, which were rescued by the glycine
site agonist D-serine, which also facilitated NMDA synaptic currents in mutant, but not in wild-type, mice. Analysis of
striatal monoamine levels revealed an apparent dopaminergic and
serotonergic hyperfunction. Behaviorally,
Grin1D481N/K483Q mice were insensitive
to acute dizocilpine pretreatment and exhibited increased startle
response but normal prepulse inhibition. Most strikingly, mutant mice
exhibited a sustained, nonhabituating hyperactivity and increased
stereotyped behavior that were resistant to suppression by
antipsychotics and the benzodiazepine site agonist Zolpidem. They also
displayed a disruption of nest building behavior and were unable to
perform a cued learning paradigm in the Morris water maze. We speculate
that the severity of NMDA receptor hypofunction in these mice may
account for their profound behavioral phenotype and insensitivity to antipsychotics.
Key words:
NMDA receptor; glycine site; schizophrenia; NMDAR1; Grin1; antipsychotics
*
T.M.B. and M.P.-E. contributed equally to this work.
Copyright © 2002 Society for Neuroscience 0270-6474/02/22156713-11$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
A. Mouri, Y. Noda, A. Noda, T. Nakamura, T. Tokura, Y. Yura, A. Nitta, H. Furukawa, and T. Nabeshima
Involvement of a Dysfunctional Dopamine-D1/N-Methyl-D-aspartate-NR1 and Ca2+/Calmodulin-Dependent Protein Kinase II Pathway in the Impairment of Latent Learning in a Model of Schizophrenia Induced by Phencyclidine
Mol. Pharmacol.,
June 1, 2007;
71(6):
1598 - 1609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Meur, M. Galante, M. C. Angulo, and E. Audinat
Tonic activation of NMDA receptors by ambient glutamate of non-synaptic origin in the rat hippocampus
J. Physiol.,
April 15, 2007;
580(2):
373 - 383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Ha, A. B. Kohn, Y. V. Bobkova, and L. L. Moroz
Molecular Characterization of NMDA-Like Receptors in Aplysia and Lymnaea: Relevance to Memory Mechanisms
Biol. Bull.,
June 1, 2006;
210(3):
255 - 270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hiroi, H. Zhu, M. Lee, B. Funke, M. Arai, M. Itokawa, R. Kucherlapati, B. Morrow, T. Sawamura, and S. Agatsuma
A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice
PNAS,
December 27, 2005;
102(52):
19132 - 19137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Moretti, J. A. Bouwknecht, R. Teague, R. Paylor, and H. Y. Zoghbi
Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome
Hum. Mol. Genet.,
January 15, 2005;
14(2):
205 - 220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Svenningsson, G. G. Nomikos, and P. Greengard
Response to Comment on "Diverse Psychotomimetics Act Through a Common Signaling Pathway"
Science,
July 9, 2004;
305(5681):
180d - 180d.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Shin, S. Korada, R. Raballo, C. S. Shashikant, A. Simeone, J. R. Taylor, and F. Vaccarino
Loss of Glutamatergic Pyramidal Neurons in Frontal and Temporal Cortex Resulting from Attenuation of FGFR1 Signaling Is Associated with Spontaneous Hyperactivity in Mice
J. Neurosci.,
March 3, 2004;
24(9):
2247 - 2258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Miyakawa, L. M. Leiter, D. J. Gerber, R. R. Gainetdinov, T. D. Sotnikova, H. Zeng, M. G. Caron, and S. Tonegawa
Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia
PNAS,
July 22, 2003;
100(15):
8987 - 8992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. F. Schwindinger, K. S. Betz, K. E. Giger, A. Sabol, S. K. Bronson, and J. D. Robishaw
Loss of G Protein gamma 7 Alters Behavior and Reduces Striatal alpha olf Level and cAMP Production
J. Biol. Chem.,
February 14, 2003;
278(8):
6575 - 6579.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|